Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Japan Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20092
20101
20121
20132
20153
20162
20172
20182
20192
20212
20231
20241
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Active, not recruiting10
Completed10
Terminated5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Merck Sharp & Dohme LLC4
Pfizer4
Genmab3
GlaxoSmithKline3
National Cancer Institute (NCI)3
AbbVie2
Amgen2
ARCAGY/ GINECO GROUP1
Arcagy Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms38
Fallopian Tube Neoplasms16
Carcinoma, Ovarian Epithelial6
Brenner Tumor3
Peritoneal Neoplasms3
Neoplasms2
Adenocarcinoma, Clear Cell1
Adenocarcinoma, Mucinous1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.